Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02674945 |
Recruitment Status :
Terminated
(Low enrollment, unable to power adequately)
First Posted : February 5, 2016
Last Update Posted : June 28, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Brain Tumor | Device: Wireless Activity tracker: Fitbit |
Study Type : | Observational |
Actual Enrollment : | 29 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase |
Actual Study Start Date : | September 2014 |
Actual Primary Completion Date : | September 2018 |
Actual Study Completion Date : | September 2018 |
Group/Cohort | Intervention/treatment |
---|---|
Wireless Activity tracker: Fitbit
Patients with brain tumor(s) will be give a wireless activity tracker (fitbit flex) to use during treatment. They will complete quality of life surveys and a sleep survey.
|
Device: Wireless Activity tracker: Fitbit
Patients will wear a Fitbit flex |
- Activity measured in steps [ Time Frame: 1 year delineated by minute ]
- Sleep [ Time Frame: per night over 1 year ]wireless activity will attempt to monitor sleep cycles when the device is worn
- Quality of Life - SF-36 [ Time Frame: months 0, 3, 6, 9, and 12 ]SF-36
- Quality of Life - Fact- Br [ Time Frame: months 0, 3, 6, 9, and 12 ]Fact-Br

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 99 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- diagnosed with primary or metastatic brain tumor
- able to wear wireless activity tracker
- able to complete QOL and sleep surveys every 3 months
Exclusion Criteria:
- unable to provide consent
- age < 18
- lack of use of the wireless activity tracker for more than 2 consecutive months

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02674945
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States, 55455 |
Principal Investigator: | David Darrow, MD MPH | University of Minnesota |
Responsible Party: | University of Minnesota |
ClinicalTrials.gov Identifier: | NCT02674945 |
Other Study ID Numbers: |
1406M51644 #2014NTLS054 ( Other Identifier: CPRC ) |
First Posted: | February 5, 2016 Key Record Dates |
Last Update Posted: | June 28, 2022 |
Last Verified: | June 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Individual data will not be shared. De-identified group data will be made available |
fitbit activity tracker sleep quality of life |